Discovery of Dengue Virus NS4B Inhibitors
The four serotypes of dengue virus (DENV-1 to -4) represent the most prevalent mosquito-borne viral pathogens in humans. No clinically approved vaccine or antiviral is currently available for DENV. Here we report a spiropyrazolopyridone compound that potently inhibits DENV both in vitro and in vivo....
Saved in:
Main Authors: | Wang, Qing-Yin, Dong, Hongping, Zou, Bin, Karuna, Ratna, Wan, Kah Fei, Zou, Jing, Susila, Agatha, Yip, Andy, Shan, Chao, Yeo, Kim Long, Xu, Haoying, Ding, Mei, Chan, Wai Ling, Gu, Feng, Seah, Peck Gee, Liu, Wei, Lakshminarayana, Suresh B., Kang, CongBao, Lescar, Julien, Blasco, Francesca, Smith, Paul W., Shi, Pei-Yong |
---|---|
Other Authors: | Diamond, M. S. |
Format: | Article |
Language: | English |
Published: |
2015
|
Online Access: | https://hdl.handle.net/10356/103770 http://hdl.handle.net/10220/38794 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Dimerization of flavivirus NS4B protein
by: Dong, Hongping, et al.
Published: (2015) -
Mapping the interactions between the NS4B and NS3 proteins of dengue virus
by: Zou, Jing, et al.
Published: (2015) -
The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development
by: Luo, Dahai, et al.
Published: (2016) -
Pharmacokinetics-Pharmacodynamics Driven Approach for Lead Optimization in Anti-Mycobacterial and Anti-Malarial Drug Discovery
by: SURESH BANGALORE LAKSHMINARAYANA
Published: (2015) -
Structure of the NS2B-NS3 protease from Zika virus after self-cleavage
by: Phoo, Wint Wint, et al.
Published: (2017)